May 3 |
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
|
May 3 |
Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
|
May 3 |
FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
|
May 3 |
Catalent, Novo Nordisk receive FTC request for more information
|
May 3 |
US FTC seeks more information on Novo Nordisk parent-Catalent deal
|
May 3 |
UPDATE 2-US FTC seeks more information on Novo Nordisk parent-Catalent deal
|
May 3 |
Job Market Cools In April: Payrolls Miss Forecasts, Wages Rise Less Than Expected
|
May 3 |
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
|
May 3 |
This Is a Huge Sigh of Relief for Novo Nordisk Investors
|
May 3 |
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
|